Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
7.47
-0.22 (-2.86%)
At close: Sep 15, 2025, 4:00 PM EDT
7.55
+0.08 (1.07%)
After-hours: Sep 15, 2025, 6:50 PM EDT
Rezolute Market Cap
Rezolute has a market cap or net worth of $649.86 million as of September 15, 2025. Its market cap has increased by 246.78% in one year.
Market Cap
649.86M
Enterprise Value
563.23M
1-Year Change
246.78%
Ranking
Category
Stock Price
$7.47
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $649.86M, an increase of 289.14%. That is a compound annual growth rate of 32.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 638.80M | 125.01% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
| Nov 10, 2020 | 167.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 672.15B |
| Johnson & Johnson | 427.84B |
| AbbVie | 381.26B |
| UnitedHealth Group | 315.67B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.02B |